Peter Slusser

This profile gathers the share dealings of Peter Slusser across 2 companies, led by Ampex Corp /DE/ and Unigene Laboratories Inc. We count 23 filings; the first trade dates from 12 January 2006 and the latest from 3 September 2010.

The open-market side counts 3 purchases for €3,537 alongside 8 sales for €63k. Sales outweigh purchases by €59k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 9 share grants and 3 option exercises. 2010 to date brings 1 purchase and no sales.

Half of the purchases are above €1,170 and half below.

Most recently, on 8 September 2010, the filings show an open-market purchase worth €1,170 in Unigene Laboratories Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.